Walden Biosciences

Walden Biosciences is a biotechnology company working to transform the treatment of #KidneyDisease.

[Ana Mulero, MBA-HCM, CPB-A 📰 @anitamulero]

.@WaldenBio enters into a research collaboration with the @UMich to expand the body of data demonstrating the causative role of soluble urokinase plasminogen activating receptor or “suPAR" in chronic kidney disease https://t.co/HQqA2amHRq

[Walden Biosciences @WaldenBio]

We are excited to announce that our CEO, Dr. Blaine McKee, will be presenting at the 32nd Annual @Oppenheimer Healthcare Conference on 3/16/2022 at 11:20am Eastern.

https://t.co/bpxcKS9mvY

[Walden Biosciences @WaldenBio]

For the team at Walden Biosciences, every day is #WorldKidneyDay because we are dedicated to delivering transformative therapies for #kidneydisease.

[Walden Biosciences @WaldenBio]

The 4th Annual #CKDSummit is kicking off! Today at 2:15p Eastern, our CSO Alex Duncan will be participating in the panel discussion on Invigorating #AKI Drug Development.

Learn More: https://t.co/jqpRDGvWex

[6th CKD Drug Development Summit @KidneyDD_Series]

Speaker #AppreciationWeek
Meet Alex Duncan, CSO at @WaldenBio who will discuss Keeping #Kidneys Calm & Carrying on Working

Learn more: https://t.co/6F44TjBQDB
#Kidney #drugdevelopment #kidneydisease #CKD #ChronicKidneyDisease #Nephrology #RenalResearch #Renal

[Walden Biosciences @WaldenBio]

Walden Biosciences is #hiring!

We are looking for a Head of Pharmacology to join our team in Cambridge, MA.

Learn more and apply here: https://t.co/iyEcxV1sCH

#JoinWalden #lifesciences #biotech

[Walden Biosciences @WaldenBio]

Interested in joining a team at the forefront of developing first-in-class therapies for individuals living with #kidney disease?

Learn more about what a career at Walden offers: https://t.co/DvyM1VCiGy

[Walden Biosciences @WaldenBio]

We wish everyone a safe and happy holiday season and a prosperous New Year!

[Walden Biosciences @WaldenBio]

Meet Elizabeth Terry-Kantor, a Research Associate II at Walden who develops cell-based assays in both our dynamin and suPAR programs to test the efficacy of our compounds and antibodies.

[Walden Biosciences @WaldenBio]

The @AJKDonline recently published a new study examining the relationship between #CKD and #COVID-19. Read the full study and the findings: https://t.co/UVCGZf5e07

[Walden Biosciences @WaldenBio]

According to the @CDCgov, chronic #kidneydisease is 38% more common for those age 65 and older. It’s important to understand the unique signs and stages of progression: https://t.co/W5nCUmNl7k

[Walden Biosciences @WaldenBio]

Kidney disease is a public health crisis. Our Senior Director of Chemistry Carmen Baldino is part of our team of researchers dedicated to developing breakthrough medicines for both rare and prevalent forms of #kidneydisease.
#LifeatWaldenBiosciences

[Walden Biosciences @WaldenBio]

“Walden aims to test its theory that targeting podocytes can make diseased kidney tissue healthy again.” Read our latest coverage in @BioCentury

https://t.co/fzGskc1ACf

[Walden Biosciences @WaldenBio]

Congratulations to our very own scientific founder @JochenReiser MD PhD who was recently voted the number 1 podocyte researcher in the world for 2011-2021! https://t.co/J5glzVUVhZ

[Walden Biosciences @WaldenBio]

Today at 8:15 AM ET our CEO Blaine McKee will be speaking at @Oppenheimer’s Fall Healthcare Life Sciences & Med Tech Summit. We are excited for this opportunity to share Walden’s interdisciplinary strategy for developing first-in-class therapies to improve #kidney health.

[Walden Biosciences @WaldenBio]

The @nkf has helpful resources and information regarding the impacts of COVID-19 on #kidney health and the relationship with #AKI. Read more: https://t.co/UywJlU5KYY

[Walden Biosciences @WaldenBio]

9/7
A study on kidney transplant recipients by @JASN_News, found those on immunosuppressive therapies mount a lower immune response to the current COVID-19 vaccination schedule compared w/ other individuals and may require 3rd booster shot for protection. https://t.co/F3YCc00iGP

[Walden Biosciences @WaldenBio]

A study published Wednesday by @JASN_News, found the more acute a COVID-19 patient’s symptoms were initially, the more likely they were to experience lingering kidney damage. Read more about the implications: https://t.co/UqLrtqB8om

[Walden Biosciences @WaldenBio]

Anyone can get chronic kidney disease #CKD, but those w/ diabetes & high blood pressure are at a heightened risk & should work w/ a doctor to keep blood sugar & blood pressure under control. Learn more from the @KidneyFund about #CKD and how to prevent it: https://t.co/bCrgEFMhJj

[Walden Biosciences @WaldenBio]

At Walden, we have a vision: a future where patients are unrestricted by #KidneyDisease. Learn how we are striving to make that vision a reality: https://t.co/ejiLaoWN4t